Skip to content
Hair growth · Riga

Finasteride in Riga, online

An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription you can collect at a pharmacy in Riga.

From€15/ month

Consultation price. The medicine is paid at your pharmacy.

  • Prescription only, if a doctor approves
  • Doctor-reviewed renewals
  • Full refund if not approved
Finasteride

Licensed EU doctors

Every case read by a registered doctor.

Reply in under 2 hours

On average, in writing, no video call.

Pay only if approved

Not approved? Refunded in full, automatically.

Rated excellent on Trustpilot

4.8 from 540+ independent reviews.

Valid across the EU

E-prescription accepted at EU pharmacies.

Local facts

Finasteride consultations in Riga

Available toResidents of Latvia
LanguagesSpanish and English
Doctor replyUnder 2 hours on average
Collected atPharmacies in Latvia · e-prescription (PDF)
About the medicine

What it is and how it works

Finasteride lowers the hormone DHT, which shrinks hair follicles in male pattern hair loss. It is taken as one tablet a day.

It works best when started early and taken consistently. The doctor explains what to expect in your chat.

Who it is for

  • Men over 18 with male pattern hair loss
  • Hair loss at the hairline or crown

Safety summary

Not for women who are or may become pregnant. Side effects are uncommon but possible.

Read the safety summary
Pricing

One consultation, one clear price

You pay for the doctor's consultation. If a prescription is issued, the medicine is paid at your own pharmacy.

  • Consultation reviewed by an EU-licensed doctor
  • Private follow-up in the in-app chat
  • Full refund if the doctor does not approve
Plan or one-off

Hair growth

  • First consultation included
  • Renewals reviewed by your doctor
  • Ongoing care in your private chat
  • Cancel anytime
Start consultation

Full refund if a review is not approved

FAQs

Your questions answered

Finasteride16 questions
What is finasteride and how does it treat hair loss?
It is a 5-alpha-reductase inhibitor that reduces the conversion of testosterone to DHT, the hormone responsible for follicle miniaturisation in male androgenetic alopecia.
Signs of stabilisation appear at 3–6 months; visible improvement from 6–12 months. Treatment is continuous: on discontinuation, effects fade over 6–12 months.
More questions
A small percentage of patients report reduced libido or changes in erectile function. These are reversible in most cases. The doctor reviews risks with you before prescribing.
Yes, a common pairing in androgenetic alopecia: finasteride halts the process, minoxidil stimulates the follicle. The doctor decides whether to combine based on your case and the pattern of loss.
Some men report sexual problems that continue after they stop, and regulators now treat this as a real signal. The patient leaflet lists persistent difficulty having an erection, persistent decrease in sex drive and persistent problems with ejaculation among effects reported after treatment is discontinued, with the frequency recorded as unknown. In the licensing trials sexual side effects were uncommon and largely settled, affecting 3.8% of men in year one against 2.1% on placebo. The UK regulator advises contacting your doctor promptly if sexual side effects appear, because the doctor may consider stopping treatment.
Yes, and you must tell whoever orders the test. Finasteride lowers prostate-specific antigen, the blood marker used to look for prostate problems. In men aged 18 to 41 the average PSA fell from 0.7 ng/ml before treatment to 0.5 ng/ml after twelve months. The product file instructs doctors to consider doubling the measured value before interpreting it, so a normal-looking result could be hiding a genuinely raised one. This still matters years later, so keep finasteride on your medication list rather than mentioning it only while you happen to be taking it.
The benefit reverses. The product file states that if treatment is stopped the beneficial effects begin to reverse by six months and return to baseline by nine to twelve months, and the patient leaflet says you are likely to lose the hair you have gained within nine to twelve months. Finasteride does not cure male pattern hair loss, it suppresses the hormonal signal driving it, so the underlying process resumes once the tablet stops. That is why a prescriber frames it as a long-term treatment rather than a short course.
Write to your doctor in the private chat in your account: describe what you notice and when it started. The doctor can adjust the plan, pause it or suggest another option. If you have severe symptoms such as difficulty breathing, swelling of the face or chest pain, call 112 or go to an emergency department straight away.
It depends on what you take. List every medicine, supplement and herbal product in the questionnaire, including ones you use only occasionally. The doctor checks for interactions before prescribing, and your pharmacist checks again when you collect Finasteride.
The doctor can consider another hair-loss treatment, a different form (tablet or solution) or a combination, depending on your pattern of loss and history. Some cases, such as sudden or patchy hair loss, need an in-person dermatologist, and the doctor tells you so.
You can message your doctor in the private chat at any time. Hair treatments take months to show an effect, so the doctor reviews progress and tolerance at each renewal, often with new scalp photos, and adjusts the plan if needed.
Yes. Hi-Doctor runs 100 % online across the EU, so if you live in Riga you can fill in the questionnaire and receive the medical review without travelling. The electronic prescription issued by the licensed doctor is valid in any EU pharmacy under Directive 2011/24/EU; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.
Through the pattern of loss, how long it has been progressing, family history and current medication. In some cases we ask for scalp photos. The doctor proposes a tailored treatment plan and adjusts it to your tolerance.
The private electronic prescription (Receta Médica Privada Electrónica) is issued by a licensed doctor in Spain. It is a PDF carrying every field required by EU Directive 2011/24/EU (patient, prescriber with country of registration, active ingredient, dose), which makes it legally recognised across all 27 EU member states. In Spanish pharmacies it is dispensed from the QR; outside Spain, the pharmacist dispenses the locally marketed equivalent of the same active ingredient.
1) Fill in an online medical questionnaire in about 4 minutes. 2) The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; sexual health is €35 per consultation and a skin consultation is €40. 3) An EU-licensed doctor reviews your case and, if appropriate, issues an electronic prescription. 4) Collect it at any EU pharmacy. If the review is not approved, the applicable fee is refunded in full.
The plan is €25/month for weight loss or €15/month (billed €45 every 90 days) for hair growth; a one-off sexual-health consultation is €35 and a skin consultation covering acne, rosacea, melasma and ageing skin is €40. Each includes a licensed doctor's review and an electronic prescription if approved. If the review is not approved, the applicable fee is refunded in full. Medication is paid for separately at the pharmacy at the price it sets.
Behind the scenes

How your doctor decides

Your answers

A licensed doctor reads your full questionnaire.

Medical judgement

The decision is clinical, never an algorithm.

Clear outcome

Approved with an e-prescription, or refunded in full.

Also for Hair growth

Related medicines

Medicine information and safety

How does Finasteride work?

DHT shrinks the hair follicle. Male pattern hair loss is driven by dihydrotestosterone, or DHT, a hormone the body makes from testosterone. A balding scalp contains miniaturised follicles and higher amounts of DHT, so each growth cycle produces a thinner, shorter hair until visible growth stops.

Finasteride blocks the converting enzyme. Finasteride is a 4-azasteroid that inhibits type II 5-alpha-reductase, the enzyme found in hair follicles that converts testosterone into DHT. The Spanish regulator's product file records that it is about 100 times more selective for the type II enzyme than for type I.

Scalp DHT falls, follicles recover. With the enzyme blocked, DHT concentrations fall in both blood and scalp tissue. That removes the signal driving miniaturisation, so some affected follicles go back to producing thicker hairs. The effect depends on continued dosing, and stopping returns the scalp to its untreated state within nine to twelve months.

How to use Finasteride

Take one tablet a day. Swallow one 1 mg tablet once daily, with or without food. The product file states there is no evidence that a higher dose improves results, so never take more than one tablet in a day.

Anchor it to a routine. NHS guidance is that the time of day does not matter, as long as it is roughly the same time each day. Attaching the tablet to something you already do daily makes a long course easier to keep up.

Swallow whole, never crush. Swallow tablets whole with water and do not break or crush them. The film coating exists specifically to stop anyone handling the tablet from touching the active ingredient during normal use.

Keep broken tablets from pregnancy. A woman who is pregnant or might become pregnant must not handle crushed or broken tablets, because absorbed finasteride can affect the external genitals of a male foetus. If contact happens, speak to a doctor.

Missed a dose? Skip it. NHS advice is to take a missed dose if fewer than six hours have passed, and otherwise to skip it and take the next one at the usual time. Never take two tablets to catch up.

Allow three to six months. The product file states that three to six months of daily treatment are generally needed before stabilisation of hair loss can be expected. Judging the medicine before then gives a misleading picture of whether it works.

Flag it before a PSA test. Finasteride lowers prostate-specific antigen. The product file instructs doctors to consider doubling the measured PSA value before interpreting it, so tell whoever orders the test that you take finasteride.

Do not donate blood. UK donor selection guidelines defer blood donation until four weeks after the last dose. The reason is to make sure a pregnant transfusion recipient is never exposed to finasteride through donated blood.

Common side effects

Stop and get urgent medical help if (seek medical help immediately): Suicidal thoughts of any kind: stop the tablets and get help now, Depression or a persistently low mood: stop taking it and call your doctor, Swelling of the lips, face, tongue or throat, or difficulty breathing, Lumps, pain, swelling or nipple discharge anywhere in the chest area, Rash that is raised, itchy, blistered or peeling, or hives, Confusion, drowsiness, dizziness or loss of consciousness after a dose

Uncommon (uncommon (≥1/1,000 to <1/100)): Less interest in sex, reported by 1.8% against 1.3% on placebo, Difficulty getting or keeping an erection, 1.3% against 0.7% on placebo, Reduced volume of semen, reported by 0.8% against 0.4% on placebo, Other disorders of ejaculation, Depressed mood or depression, Any sexual side effect: 3.8% in year one, falling to 0.6% later

Reported since launch, frequency unknown (not known (frequency cannot be estimated from the available data)): Breast tenderness or breast enlargement, Breast cancer in men, Testicular pain, Blood in the semen, Palpitations, a noticeable heartbeat, Raised liver enzymes on a blood test, Anxiety, and suicidal ideation, Male infertility or poor semen quality, Sexual dysfunction that persists after treatment is stopped, Allergic reactions including rash, itching, hives and swelling

Do not use Finasteride if

  • You are a woman: finasteride is contraindicated in women and did not work for hair loss in female trials.
  • You are pregnant or could become pregnant, because finasteride can affect the external genitals of a male foetus.
  • You are under 18: there are no data demonstrating efficacy or safety in children or adolescents.
  • You are allergic to finasteride or to any other ingredient in the tablet.
  • You already take finasteride 5 mg or dutasteride for an enlarged prostate: these must not be combined.
  • You have inherited galactose intolerance, total lactase deficiency or glucose-galactose malabsorption, because the tablets contain lactose.
  • You have a history of depression or suicidal thoughts and have not disclosed it: regulators advise reviewing this before prescribing.
  • You have a PSA test or prostate assessment planned and have not told the clinician you take finasteride.
  • You have liver problems: the effect of hepatic impairment on finasteride has not been studied.
  • You are about to donate blood, which UK guidelines defer until four weeks after the last dose.

Medicines and substances that interact

  • Finasteride 5 mg (for enlarged prostate): Same active ingredient at five times the dose, with no extra hair benefit. Only one is prescribed. The prescriber will not combine them.
  • Dutasteride: Another 5-alpha-reductase inhibitor, so the two act on the same pathway. The prescriber avoids combining them and selects one.
  • Strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir): May raise finasteride blood levels, which the product file judges unlikely to matter clinically. Noted in the record. A dose change is not normally needed.
  • Strong CYP3A4 inducers (e.g. rifampicin, carbamazepine): May lower finasteride blood levels through the same enzyme system. The prescriber reviews the response rather than altering the dose.
  • Topical minoxidil: The leaflet states no information is available on using the two together. The prescriber decides case by case and records the reasoning.
  • PSA blood test (not a medicine): Finasteride lowers the PSA reading, which can mask a genuinely raised result. The prescriber flags current finasteride use on the test request.
  • Blood or plasma donation: Donated blood could expose a pregnant transfusion recipient to finasteride. UK guidance defers donation until four weeks after the last dose.

References

  1. Propecia 1 mg Film-Coated Tablets: Summary of Product Characteristics electronic Medicines Compendium (emc), 2025
  2. Propecia 1 mg Film-Coated Tablets: Package Leaflet, Information for the user electronic Medicines Compendium (emc), 2025
  3. Ficha Técnica: finasterida cinfa 1 mg comprimidos recubiertos con película EFG AEMPS CIMA (Spanish Agency for Medicines and Medical Devices), 2025
  4. Finasteride 1 mg film-coated tablets: Summary of Product Characteristics electronic Medicines Compendium (emc), 2025
  5. Finasteride 1 mg tablets: Summary of Product Characteristics (PSA and prostate cancer sections) electronic Medicines Compendium (emc), 2025
  6. Finasteride in the treatment of men with androgenetic alopecia (Finasteride Male Pattern Hair Loss Study Group) Journal of the American Academy of Dermatology, via PubMed, 1998
  7. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia European Journal of Dermatology, via PubMed, 2002
  8. Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines European Medicines Agency, 2025
  9. Finasteride- and dutasteride-containing medicinal products: Article 31 referral European Medicines Agency, 2025
  10. Finasteride and dutasteride: updated safety warnings for psychiatric side effects and sexual dysfunction MHRA Drug Safety Update, 2025
  11. Side effects of finasteride NHS, 2025
  12. How and when to take finasteride NHS, 2025
  13. Fertility and pregnancy while taking finasteride NHS, 2025
  14. Common questions about finasteride NHS, 2025
  15. Avodart 0.5 mg soft capsules (dutasteride): Summary of Product Characteristics electronic Medicines Compendium (emc), 2025
  16. Regaine for Men Extra Strength Scalp Solution 5% w/v (minoxidil): Summary of Product Characteristics electronic Medicines Compendium (emc), 2025
  17. Do my medicines mean I can't give blood? (citing the UK Whole Blood and Component Donor Selection Guidelines) The Pharmaceutical Journal, Royal Pharmaceutical Society, 2013

Also available in

Online doctor by city

Also available in

Keep the hair you've got

A doctor replies in under 2 hours on average.

Start consultationNo charge unless a doctor approves your treatment.
All content on this page has been medically reviewed by: Dr. Alejandro Infante, General medicine, on 27 July 2026. Registration: 080869277 View profile

Pay nothing if a doctor doesn't approve your treatment. Every consultation is fully refundable. How refunds work